UniProt ID | ORC6_HUMAN | |
---|---|---|
UniProt AC | Q9Y5N6 | |
Protein Name | Origin recognition complex subunit 6 | |
Gene Name | ORC6 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 252 | |
Subcellular Localization | Nucleus. | |
Protein Description | Component of the origin recognition complex (ORC) that binds origins of replication. DNA-binding is ATP-dependent. The specific DNA sequences that define origins of replication have not been identified yet. ORC is required to assemble the pre-replication complex necessary to initiate DNA replication. Does not bind histone H3 and H4 trimethylation marks H3K9me3, H3K27me3 and H4K20me3.. | |
Protein Sequence | MGSELIGRLAPRLGLAEPDMLRKAEEYLRLSRVKCVGLSARTTETSSAVMCLDLAASWMKCPLDRAYLIKLSGLNKETYQSCLKSFECLLGLNSNIGIRDLAVQFSCIEAVNMASKILKSYESSLPQTQQVDLDLSRPLFTSAALLSACKILKLKVDKNKMVATSGVKKAIFDRLCKQLEKIGQQVDREPGDVATPPRKRKKIVVEAPAKEMEKVEEMPHKPQKDEDLTQDYEEWKRKILENAASAQKATAE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
23 | Ubiquitination | AEPDMLRKAEEYLRL CCHHHHHHHHHHHHH | 57.07 | - | |
34 | Ubiquitination | YLRLSRVKCVGLSAR HHHHHCCEECEECCC | 23.30 | - | |
65 | Methylation | WMKCPLDRAYLIKLS HHCCCCCHHHHHHHH | 32.58 | 115486047 | |
67 | Phosphorylation | KCPLDRAYLIKLSGL CCCCCHHHHHHHHCC | 15.17 | 22817900 | |
70 | Ubiquitination | LDRAYLIKLSGLNKE CCHHHHHHHHCCCHH | 33.72 | - | |
72 | Phosphorylation | RAYLIKLSGLNKETY HHHHHHHHCCCHHHH | 35.91 | 29978859 | |
76 | Acetylation | IKLSGLNKETYQSCL HHHHCCCHHHHHHHH | 57.38 | 26051181 | |
76 | Ubiquitination | IKLSGLNKETYQSCL HHHHCCCHHHHHHHH | 57.38 | - | |
78 | Phosphorylation | LSGLNKETYQSCLKS HHCCCHHHHHHHHHH | 28.59 | 29978859 | |
79 | Phosphorylation | SGLNKETYQSCLKSF HCCCHHHHHHHHHHH | 10.26 | 29978859 | |
81 | Phosphorylation | LNKETYQSCLKSFEC CCHHHHHHHHHHHHH | 15.82 | 29978859 | |
119 | Ubiquitination | NMASKILKSYESSLP HHHHHHHHHHHHCCC | 55.24 | - | |
168 | Acetylation | MVATSGVKKAIFDRL CCCCHHHHHHHHHHH | 39.76 | 7682077 | |
168 | Ubiquitination | MVATSGVKKAIFDRL CCCCHHHHHHHHHHH | 39.76 | - | |
177 | Ubiquitination | AIFDRLCKQLEKIGQ HHHHHHHHHHHHHHH | 63.61 | - | |
181 | Ubiquitination | RLCKQLEKIGQQVDR HHHHHHHHHHHCCCC | 61.81 | - | |
195 | Phosphorylation | REPGDVATPPRKRKK CCCCCCCCCCCCCCC | 33.40 | 19664994 | |
202 | Ubiquitination | TPPRKRKKIVVEAPA CCCCCCCCEEEECCH | 44.78 | - | |
210 | Sumoylation | IVVEAPAKEMEKVEE EEEECCHHHHHHHHC | 57.44 | 28112733 | |
210 | Ubiquitination | IVVEAPAKEMEKVEE EEEECCHHHHHHHHC | 57.44 | - | |
210 | Acetylation | IVVEAPAKEMEKVEE EEEECCHHHHHHHHC | 57.44 | 26051181 | |
214 | Acetylation | APAKEMEKVEEMPHK CCHHHHHHHHCCCCC | 54.35 | 22361695 | |
221 | Acetylation | KVEEMPHKPQKDEDL HHHCCCCCCCCCCCH | 43.18 | 7826271 | |
229 | Phosphorylation | PQKDEDLTQDYEEWK CCCCCCHHHCHHHHH | 31.54 | 17525332 | |
232 | Phosphorylation | DEDLTQDYEEWKRKI CCCHHHCHHHHHHHH | 13.11 | 28796482 | |
236 | Ubiquitination | TQDYEEWKRKILENA HHCHHHHHHHHHHHH | 47.28 | - | |
238 | Ubiquitination | DYEEWKRKILENAAS CHHHHHHHHHHHHHH | 48.17 | - | |
245 | Phosphorylation | KILENAASAQKATAE HHHHHHHHHHHHHCC | 28.90 | 25159151 | |
248 | Ubiquitination | ENAASAQKATAE--- HHHHHHHHHHCC--- | 47.63 | 21906983 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
195 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ORC6_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ORC6_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
613803 | Meier-Gorlin syndrome 3 (MGORS3) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-195, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-229, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-195, AND MASSSPECTROMETRY. |